B. Braun syringes recalled
This article was originally published in The Gray Sheet
Executive Summary
The supplier of B. Braun's pre-filled heparin and saline flush syringes, AM2PAT, recalls all lots of the products Jan. 18 due to potential bacterial contamination with Serratia marcescens, which could lead to life-threatening infections. The syringes are also marketed under AM2PAT's private label, Sierra. B. Braun, which has not yet determined the financial impact of the recall, is temporarily offering clinically equivalent products from a different supplier branded Syrex